Daytona Street Capital LLC Takes Position in Carter Bankshares, Inc. $CARE
Daytona Street Capital LLC has acquired a new stake in Carter Bankshares, Inc. (NASDAQ:CARE) during the fourth quarter, purchasing 52,536 shares valued at approximately $1.03 million. Other institutional investors have also adjusted their positions in the company, which recently exceeded Q4 EPS expectations. Carter Bankshares maintains a "Buy" consensus rating from analysts with a price target of $22.00, and its stock is trading near its 52-week high.
Carter Bankshares (NASDAQ:CARE) Reaches New 12-Month High - Still a Buy?
Carter Bankshares (NASDAQ:CARE) recently hit a new 52-week high of $23.71, trading at $23.60 with a market capitalization of $523 million. Despite an average analyst target price of $22.00, analysts have largely upgraded the stock to a "Buy" rating. The company reported better-than-expected EPS and has seen increased institutional investment, suggesting continued growth potential.
Compared to Estimates, Carter Bankshares (CARE) Q3 Earnings: A Look at Key Metrics
This article analyzes Carter Bankshares' (CARE) Q3 earnings performance in comparison to analyst estimates. It will likely detail key financial metrics from the earnings report and discuss how the results stack up against expectations, providing insight into the company's recent financial health.
CARE Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for Carter Bankshares Inc (CARE). It indicates a "Strong Buy" overall consensus based on a proprietary analysis of 14 technical signals as of April 2, 2026, with 9 indicators signaling buy and 5 indicating sell. The analysis details momentum indicators like RSI and MACD, support and resistance levels, and performance relative to moving averages, noting the stock is currently trading in overbought territory.
Carter Bankshares, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Performance
Carter Bankshares, Inc. has recently adjusted its stock valuation to $22.88, reflecting a strong performance with a 36.92% return over the past year, significantly outperforming the S&P 500. The company's financial metrics include a P/E ratio of 14, a price-to-book value of 1.06, and a return on equity of 7.41%. Its valuation relative to peers like Red River Bancshares, Guaranty Bancshares, and Peoples Financial Services Corp. highlights the competitive and varied landscape of the regional banking sector.
Carter Bankshares Hits New 52-Week High of $22.75, Up 72.76%
Carter Bankshares, Inc. has reached a new 52-week high of $22.75, marking a 72.76% increase from its 52-week low. The regional bank, with a market capitalization of $445 million, has outperformed the S&P 500's 13.39% gain over the same period. The company exhibits competitive valuation with a P/E ratio of 14.00, a return on equity of 7.41%, and a price-to-book ratio of 1.06.
Carter Bankshares (NASDAQ:CARE) Reaches New 1-Year High - Here's Why
Carter Bankshares (NASDAQ:CARE) hit a new 52-week high of $22.75, trading above its 50-day and 200-day moving averages, following several analyst upgrades to "Buy" or "Hold" ratings. The company exceeded Q4 EPS expectations but had slightly lower revenue than forecast. CARE has a market capitalization of $504 million and institutional ownership of about 41.5%.
Carter Bankshares completes sale of nonperforming loans for $289.48 million
Carter Bankshares (NASDAQ: CARE) announced the sale of $289.48 million in nonperforming loans, which had been reduced to judgments, related to entities tied to James C. Justice, II. This transaction significantly cleans up the bank's balance sheet, impacting its financial metrics by increasing tangible book value per common share by approximately $3.49. The company, which is profitable and has seen its stock deliver a 22% return over the past year, is expected to provide further details in its upcoming earnings report.
Vanguard (CARE) amends Schedule 13G/A, reports 0 shares after realignment
The Vanguard Group has filed an Amendment No. 2 to a Schedule 13G/A for Carter Bankshares Inc (CARE), reporting zero beneficial ownership subsequent to an internal realignment. This amendment indicates that Vanguard now holds 0 shares and 0% of the class, as certain subsidiaries will begin reporting separately in accordance with SEC Release No. 34-39538. The filing emphasizes a procedural change in reporting structure rather than a market transaction or sale of shares.
Carter Bankshares, Inc. Files Form 8-K with SEC – Key Details, Stock Info, and Forward-Looking Statements (March 26, 2026)
Carter Bankshares, Inc. (NASDAQ: CARE) has filed an 8-K report detailing the sale of nonperforming loans for $289.48 million, which is expected to significantly improve its financial condition. This transaction is projected to increase tangible book value by approximately $3.49 per share and drastically reduce nonperforming loans from $243.98 million to $29.96 million. Further details will be disclosed in their Q1 2026 earnings release and Form 10-Q.
Carter Bankshares completes sale of nonperforming loans for $289.48 million
Carter Bankshares announced its subsidiary, Carter Bank & Trust, has sold all nonperforming loans related to James C. Justice, II for $289.48 million in cash. This transaction significantly cleans up the bank's balance sheet by removing $209.48 million in nonaccrual loans and is expected to increase tangible book value per common share by approximately $3.49. Pro forma financials show a substantial reduction in nonperforming loans and an increase in total assets and loans.
Carter Bankshares (CARE) offloads nonperforming loans, lifting tangible book value
Carter Bankshares (CARE) has sold approximately $209.48 million in nonperforming, nonaccrual loans associated with James C. Justice, II entities, receiving $289.48 million in cash. This transaction is expected to significantly improve the bank's asset quality by reducing nonperforming loans and also increase tangible book value per common share by an estimated $3.49. The company will provide final financial impacts in its Q1 2026 filings.
Carter Bankshares sells $209.5M nonperforming loans for $289.48M; tangible book value up ~$3.49
Carter Bankshares (CARE) successfully sold $209.48 million in nonperforming loans for $289.48 million, leading to an estimated increase of approximately $3.49 in tangible book value per common share. The transaction involved the sale of loans associated with James C. Justice II to an unaffiliated third party. The full financial impact of this sale is expected to be detailed in the company's Q1 earnings and 10-Q report.
CARE SEC Filings - Carter Bankshares Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors to access Carter Bankshares Inc. (CARE) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, and 8-K material event forms. It details the types of information found in these filings, such as financial condition, capital, risk factors, and insider trading activities. The platform also offers AI-powered summaries and real-time updates to help investors analyze key disclosures efficiently.
Carter Bankshares, Inc. (CARE) beats Q4 earnings estimates
Carter Bankshares, Inc. (CARE) announced its fourth-quarter earnings, surpassing analyst expectations. The company reported adjusted earnings per share of $0.62, outperforming the consensus estimate of $0.58. However, revenue for the quarter came in below analyst projections.
Carter Bankshares (CARE) CEO uses 819 shares for tax withholding, retains 67,467
Carter Bankshares (CARE) CEO Van Dyke Litz reported a tax-related disposition of 819 common shares at a price of $20.98 per share. This transaction was for tax withholding purposes and not an open-market sale, leaving the CEO with a direct holding of 67,467 shares. The filing indicates this was a routine administrative adjustment and not a change in investment position.
Carter Bankshares (NASDAQ: CARE) EVP reports 309-share tax withholding
Jane Ann Davis, EVP and Chief Administrative Officer of Carter Bankshares (NASDAQ: CARE), reported a tax-related disposition of 309 shares of common stock. These shares were withheld at $20.98 per share to cover tax obligations, not through an open-market sale. Following this transaction, Davis directly holds 12,430 shares of the company.
Carter Bankshares (CARE) CFO covers tax liability with 435 company shares
Wendy S. Bell, the Senior Executive VP and CFO of Carter Bankshares, Inc. (CARE), had 435 shares of common stock withheld on March 4, 2026, to cover tax obligations. The shares were valued at $20.98 per share. Following this transaction, Bell directly holds 40,223 shares of Carter Bankshares common stock.
Carter Bankshares (CARE) president logs routine 638-share tax withholding
Bradford N. Langs, President and Chief Strategy Officer of Carter Bankshares (CARE), reported a Form 4 transaction for a routine tax-withholding event. On March 4, 2026, he disposed of 638 shares at $20.98 per share to cover tax obligations, rather than an open-market sale. Following this activity, Langs directly owns 32,593 shares of Carter Bankshares common stock.
Carter Bankshares (CARE) COO reports 411-share tax-w`ithholding move
Matthew M. Speare, Senior Executive Vice President and Chief Operating Officer at Carter Bankshares (CARE), reported a tax-related disposition of 411 common shares. These shares were withheld at a price of $20.98 each to cover tax obligations, rather than being sold in the open market. Following this transaction, Speare directly holds 26,793 shares of Carter Bankshares common stock.
Carter Bankshares 2025 10-K: $232.2M Interest Income, $1.38 EPS
Carter Bankshares (CARE) reported a total interest income of $232.2 million and diluted earnings per share of $1.38 for the fiscal year ending December 31, 2025. The company's net income was $31.4 million, driven by a 14.3% increase in net interest income due to loan growth and improved loan yields. Strategic initiatives included brand relaunch, branch renovations, new websites, branch acquisition in North Carolina, and continued focus on resolving nonaccrual credit relationships.
CARE (CARE) CFO receives restricted stock grants, uses shares for taxes
Carter Bankshares, Inc. (CARE) CFO Wendy S. Bell reported receiving two restricted stock awards totaling 5,805 common shares on February 25, 2026, with different vesting schedules. On February 14, 2026, she also disposed of 554 shares at $22.01 each to cover tax obligations. Following these transactions, her direct holdings increased to 40,658 shares.
Carter Bankshares (CARE) SEVP receives stock awards, wholds shares for taxes
Carter Bankshares (CARE) SEVP and Chief Credit Officer, Tony E. Kallsen, reported receiving multiple common stock awards totaling 4,358 shares on February 25, 2026, with vesting periods of three years. Earlier, on February 14, 2026, Kallsen disposed of 351 shares at $22.01 each to cover tax obligations related to equity compensation, rather than through an open-market sale. Following these transactions, Kallsen's direct holdings in Carter Bankshares common stock increased to 20,619 shares.
Carter Bankshares (CARE) CEO granted 12,068 shares, withholds 1,158 for taxes
Carter Bankshares CEO Van Dyke Litz was granted a total of 12,068 common shares through two restricted stock awards on February 25, 2026. These awards have different vesting schedules: one vests over three years (one-third annually) and the other uses a three-year cliff vest. Additionally, 1,158 shares were withheld on February 14, 2026, at $22.01 per share to cover tax obligations related to equity compensation.
Carter Bankshares (CARE) EVP reports stock award and tax-share disposition
Carter Bankshares, Inc.'s EVP and Chief Administrative Officer, Jane Ann Davis, conducted two stock transactions. She received a grant of 1,230 restricted shares with a three-year vesting schedule and disposed of 291 shares at $22.01 each to cover tax obligations. Following these transactions, Davis directly holds 12,739 common shares of CARE.
Carter Bankshares (CARE) COO gains new restricted stock awards
Carter Bankshares, Inc. COO Matthew M. Speare was granted 5,295 shares of common stock through two restricted stock awards on February 25, 2026. These grants, received at no purchase price, increased his holdings to 27,204 shares. The awards have different vesting schedules: one vests at one-third each year for three years, and the other vests entirely after three years.
Carter Bankshares (CARE) EVP granted 1,002 restricted shares
Arthur Loran Adams, Executive Vice President and Director of Regulatory Risk Management at Carter Bankshares (CARE), was granted 1,002 restricted shares of common stock. This award vests over three years in equal annual installments and brings his direct ownership to 11,412 shares. The transaction, reported via SEC Form 4, is an equity-based compensation rather than a market purchase.
CARE Financials: Income Statement, Balance Sheet & Cash Flow
This article provides a comprehensive financial overview of Carter Bankshares Inc (CARE), detailing its income statement, balance sheet, cash flow, and key financial ratios through FY2024 and Q3'25. It highlights the company's financial health signals, including profitability, growth, leverage, liquidity, cash flow, and returns, and includes a Piotroski F-Score and earnings quality assessment. The data is derived from SEC filings and is presented with year-over-year growth rates and compound annual growth rates.
Implied Volatility Surging for Carter Bankshares Stock Options
Implied volatility for Carter Bankshares (CARE) stock options, particularly the March 20, 2026 $12.50 Put, is surging, indicating that investors are anticipating a significant price movement. This comes as analysts, according to Zacks Rank, currently rate Carter Bankshares as a #4 (Sell) with recent downward revisions to earnings estimates, suggesting potential for a developing trade strategy for options traders.
Implied Volatility Surging for Carter Bankshares Stock Options
Implied volatility for Carter Bankshares Inc. (CARE) stock options is surging, particularly for the March 20, 2026 $12.50 Put, indicating expectations of a significant price movement. Analysts currently rate Carter Bankshares as a Zacks Rank #4 (Sell), with recent earnings estimate revisions showing a downward trend, suggesting this high implied volatility could present a trading opportunity. Options traders often use such high implied volatility to sell premium, hoping the underlying stock does not move as much as expected by expiration.
Implied Volatility Surging for Carter Bankshares Stock Options
Implied volatility for Carter Bankshares (CARE) stock options is surging, particularly for the March 20, 2026 $12.50 Put, indicating expectations of a significant price move. Despite this, analysts currently rate Carter Bankshares as a Zacks Rank #4 (Sell), with recent downward revisions to earnings estimates. This suggests that while options traders anticipate volatility, the underlying fundamental outlook is cautious, potentially creating opportunities for options selling strategies.
Carter Bank Names Kimberly Schaufenbuel EVP, Chief Human Resources Officer
Carter Bank has appointed Kimberly Dempsey Schaufenbuel as Executive Vice President and Chief Human Resources Officer, effective February 2, 2026. Schaufenbuel brings over 20 years of HR experience and will focus on strengthening talent, culture, and leadership development to support the bank's long-term success. She emphasized her commitment to fostering an environment where employees feel heard, respected, and equipped to perform their best work.
Carter Bankshares Announces $10 Million Share Repurchase Program
Carter Bankshares, Inc. announced a $10 million common share repurchase program authorized by its board of directors. The program, which is subject to regulatory non-objection and market conditions, will be carried out over 12 months. An analyst currently rates CARE stock as a "Buy" with a $22.50 price target, and TipRanks' AI Analyst assesses it as "Outperform" due to solid financial performance and technicals.
Carter Bankshares, Inc. announces an Equity Buyback for $10 million worth of its shares.
Carter Bankshares, Inc. (NasdaqGS:CARE) has announced a new share repurchase program, authorizing the buyback of up to $10 million of its common stock. This program will be valid for 12 months, contingent upon receiving non-objection from the Federal Reserve Bank of Richmond. The bank aims to return value to its shareholders through this initiative.
Carter Bankshares Announces $10 Million Share Repurchase Program
Carter Bankshares, Inc. announced a $10 million share repurchase program on February 2, 2026. This program allows for the repurchase of common stock in open market or private transactions, contingent on Federal Reserve non-objection. The timing and amount of repurchases will depend on market conditions.
Carter Bankshares updates Q4 2025 investor presentation
Carter Bankshares (CARE) has updated its investor presentation for Q4 and full-year 2025, highlighting strong financial performance, including a 7.0% year-over-year increase in total portfolio loans and robust liquidity. The presentation also details strategic expansions, a brand refresh, and a seasoned leadership team aimed at strengthening its competitive position in Southeastern markets. Analysts currently rate CARE as a Buy with a $21.00 price target.
Carter Bankshares (NASDAQ:CARE) Upgraded at Wall Street Zen
Carter Bankshares (NASDAQ:CARE) has been upgraded from a "sell" to a "hold" rating by Wall Street Zen, contributing to an overall "Moderate Buy" consensus from analysts with an average target price of $22.00. The company recently reported quarterly EPS of $0.41, surpassing consensus estimates, though revenue slightly missed expectations. Shares currently trade around $21.41, reflecting a market capitalization of approximately $473 million.
Carter Bankshares updates Q4 2025 investor presentation
Carter Bankshares (CARE) has released an updated investor presentation for Q4 and full-year 2025, detailing its financial performance and strategic initiatives. The presentation highlights significant loan growth, strong liquidity, geographic expansion in the Southeast, and a brand refresh. TipRanks' AI Analyst, Spark, rates CARE as Outperform due to its robust financials and positive corporate developments.
Carter Bankshares (CARE) Net Margin Strength Challenges Bearish Credit Narratives In FY 2025 Results
Carter Bankshares (CARE) reported strong FY 2025 results with a 20% net margin and trailing EPS of $1.40, marking a 29.2% year-over-year earnings growth. Despite this profitability, the company faces skepticism due to a high non-performing loan ratio of 6.7% with only 29% allowance coverage, presenting a risk to future earnings. However, the stock trades below its DCF fair value, suggesting the market is already pricing in these credit risks.
Carter Bankshares, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Carter Bankshares, Inc. reported its financial results for the fourth quarter and full year 2025, announcing a quarterly net income of $8.5 million ($0.38 diluted EPS) and an annual net income of $31.4 million ($1.38 diluted EPS). The company saw an increase in total portfolio loans to $3.8 billion, reflecting positive momentum in its commercial lending, and maintained a well-capitalized position despite ongoing impacts from nonaccrual loans related to certain credit relationships. Looking ahead, the bank is optimistic about margin expansion and growth, particularly with anticipated reductions in short-term interest rates by the Federal Reserve.
Carter Bankshares (NASDAQ:CARE) Issues Quarterly Earnings Results
Carter Bankshares (NASDAQ:CARE) reported strong quarterly earnings, with an EPS of $0.41, surpassing analyst estimates of $0.33. Despite revenue of $39.83 million falling slightly short of estimates, the bank demonstrated a healthy return on equity of 7.65% and a net margin of 12.37%. Shares saw an increase in midday trading, and the company maintains a "Moderate Buy" rating with an average analyst price target of $22.00.
Carter Bankshares Q4 EPS beats expectations on loan growth
Carter Bankshares (CARE) announced its Q4 earnings, which surpassed analysts' expectations. The positive results are attributed to strong loan growth during the quarter.
Carter Bankshares, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Carter Bankshares, Inc. reported strong financial results for the fourth quarter and full year 2025, with significant increases in net income and diluted EPS compared to the previous year. The company achieved substantial loan growth, particularly in commercial real estate and industrial loans, while also making progress in reducing its nonperforming loan balance through curtailment payments. CEO Litz H. Van Dyke expressed optimism for 2026, citing margin expansion, solid loan growth, and strategic initiatives to resolve nonperforming credits.
Carter Bankshares, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Carter Bankshares, Inc. announced its financial results for the fourth quarter and full year 2025, reporting a substantial increase in net income for both periods. The company posted $8.5 million in net income for Q4 2025 and $31.4 million for the full year 2025, indicating strong financial performance despite ongoing impacts from nonaccrual loans. Total portfolio loans increased by 6.5% on an annualized basis, reflecting positive momentum in its commercial lending segment, and the company is strategically expanding into new markets.
Zacks Research Upgrades Carter Bankshares (NASDAQ:CARE) to Hold
Zacks Research has upgraded Carter Bankshares (NASDAQ:CARE) from a "strong sell" to a "hold" rating. The bank currently holds a consensus "Moderate Buy" rating with an average target price of $22.00 from analysts, despite missing its recent quarterly earnings estimates. Insider activity shows a director sold shares, while institutional investors have increased their stakes in the company.
Why (CARE) Price Action Is Critical for Tactical Trading
This article analyzes Carter Bankshares Inc. (NASDAQ: CARE) price action, presenting AI-generated trading strategies. It highlights a strong near-term sentiment potentially leading to a long-term positive bias, with specific entry, target, and stop-loss levels for position, momentum, and risk hedging strategies. The analysis also provides multi-timeframe signal analysis, showing current support and resistance levels.
Understanding Momentum Shifts in (CARE)
This article analyzes momentum shifts for Carter Bankshares Inc. (CARE), highlighting strong near-term sentiment potentially leading to mid-term neutrality and long-term positive bias. It presents different AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal strength, support, and resistance levels for CARE.
Carter Bankshares (NASDAQ:CARE) Rating Increased to Strong-Buy at Freedom Capital
Freedom Capital upgraded Carter Bankshares (NASDAQ:CARE) to a "strong-buy" rating. Despite differing analyst opinions leading to a "Moderate Buy" average, the stock trades near $19.87 with an average target price of $22.00. Carter Bankshares reported Q3 EPS of $0.26, missing consensus, on revenue of $39.09M, and has a market cap of approximately $439M.
Carter Bankshares (NASDAQ:CARE) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded Carter Bankshares (NASDAQ:CARE) from "sell" to "hold" as other analysts have given the stock a consensus "Hold" rating with a target price of $22.00. The company missed its quarterly EPS expectations, reporting $0.26 versus $0.39 expected, though revenue was nearly in line. Institutional investors have increased their stakes, while an insider reduced their position by selling 1,901 shares.
Fourthstone LLC Acquires 139,960 Shares of Carter Bankshares, Inc. $CARE
Fourthstone LLC increased its stake in Carter Bankshares, Inc. (NASDAQ:CARE) by 31.5% during the second quarter, acquiring an additional 139,960 shares and bringing its total holdings to 583,893 shares valued at $10.125 million. Other institutional investors like Nuveen LLC and Diversified Trust Co also made significant investments. The company's stock performance shows a 52-week low of $13.60 and a high of $20.53, with a market capitalization of $436.28 million.
